British Journal of Urology · 1995 · 11 citations · 17 references
MedicineOncologyUrologyGenitourinary OncologyProstate DiseaseSurgical OncologyProstate CancerProstate InfectionProstate PathologyProstate SurgeryProstate-specific Antigen TestingRadical ProstatectomyPrognosis Of Prostate DiseaseProstate Cancer DiagnosisProstate-specific Antigen Test InterpretationProstate-specific Antigen Test PerformanceProstate-specific Antigen ThresholdsRetropubic ProstatectomyRetropubic Radical ProstatectomyRisk Stratification Using Prostate-specific Antigen
OBJECTIVE: To assess the relationship of prostate-specific antigen (PSA) obtained under optimal conditions with the presence or absence of organ-confined prostate cancer following radical prostatectomy. PATIENTS AND METHODS: The medical records of 300 consecutive patients who underwent radical retropubic prostatectomy were retrospectively reviewed. Ninety-three patients were excluded who had a pre-operative PSA level potentially altered by various factors (prostate infection, manipulation or instrumentation). RESULTS: A pre-operative PSA value < 4 ng/mL accurately predicted pathologically confined disease in 42 of 51 patients (82%) which contrasted with extracapsular disease in 74 of 84 patients (88%) who had a PSA value > 10 ng/mL. One of the 53 patients with a PSA > 15 ng/mL had organ-confined disease at surgery. CONCLUSION: These data demonstrate that optimal serum PSA values correlate well with pathological stage.
17
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
Thomas A. Stamey, Norman Yang, Alan R. Hay et al. · New England Journal of Medicine · 1987 · 2.5K citations
Screening for Prostatic Carcinoma with Prostate Specific Antigen
Michael K. Brawer, Michael Chetner, Jeanette Beatie et al. · The Journal of Urology · 1992 · 624 citations
Medicine, Endocrinology, Oncology +14